Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic Cardiomyopathy.

Circulation. Heart failure - 1 Jun 2023

Sucharov Carmen C, Neltner Bonnie, Pietra Ashley E, Karimpour-Fard Anis, Patel Joshen, Ho Carolyn Y, Miyamoto Shelley D

Abstract excerpt

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy. Pathogenic germline variation in genes encoding the sarcomere is the predominant cause of disease. However diagnostic features, including unexplained left ventricular hypertrophy, typically do not develop until late adolescence or after. The early stages of disease pathogenesis and the mechanisms underlying the transition to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy, Hypertrophic
Share to Heart Failure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MicroRNAs

Share to Mutation

Share to Phenotype

Share to Sarcomeres

Source

Open in PubMed Open full text

Identifiers

PMID: 36880380
DOI: 10.1161/CIRCHEARTFAILURE.122.010291
PMCID: PMC10293059

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic Cardiomyopathy.PMID 36880380Read ↗

MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the ArtSemantic proximity Read ↗

Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Phenotypic Spectrum of Subclinical Sarcomere-Related Hypertrophic Cardiomyopathy and Transition to Overt Disease.Semantic proximity Read ↗

Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling PathwaysSemantic proximity Read ↗

Outcomes and phenotypic expression of rare variants in hypertrophic cardiomyopathy genes amongst UK Biobank participantsSemantic proximity Read ↗

MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkersSemantic proximity Read ↗

Circulating miR-499a-5p Is a Potential Biomarker of MYH7-Associated Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Circulating microRNAs as potential biomarkers of hypertrophic cardiomyopathy phenotypic expressionSemantic proximity Read ↗

Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.Semantic proximity Read ↗

Cardiovascular Health and Outcomes in Carriers With Genetic Variants of Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Hypertrophic cardiomyopathy: preclinical and early phenotype.Semantic proximity Read ↗

The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.